A study to assess efficacy of Letermovir Prophylaxis on Cytomegalovirus infection after allogeneic hematopoietic cell transplantation
Latest Information Update: 28 Apr 2022
At a glance
- Drugs Letermovir (Primary)
- Indications Cytomegalovirus infections
- Focus Expanded access; Therapeutic Use
- Acronyms French Temporary Authorization of Use (ATU) compassionate program
Most Recent Events
- 28 Apr 2022 New trial record
- 01 Mar 2022 Results published in the Journal of Clinical Virology